Dyax - Advancing Novel Biotherapeutics

Dedicated to finding new solutions for patients in need.

Corporate Governance - Board of Directors

Executive Officers | Board of Directors
Board of Directors
Henry E. Blair
Chairman, Former President and Chief Executive Officer, Dyax Corp.
Constantine E. 
Anagnostopoulos, Ph.D.

Chairman, Kereos, Inc.
Susan B. Bayh, J.D.
Former Commissioner of the International Commission, U.S. and Canada
Gustav A. Christensen*
President and Chief Executive Officer, Dyax Corp.
James W. Fordyce
Managing Partner, MEDNA Partners LLC
Mary Ann Gray, Ph.D.
Founder and President, Gray Strategic Advisors, LLC
Thomas L. Kempner
Chairman and Chief Executive Officer, Loeb Partners Corporation
Henry R. Lewis, Ph.D.
Former director, Genzyme Corporation
David J. McLachlan
Former Executive Vice President and Chief Financial Officer, Genzyme Corporation
Executive Officers
Gustav A. Christensen*
President and Chief Executive Officer
Ivana Magovcevic-Liebisch*, Ph.D. J.D.
Executive Vice President Corporate Development and General Counsel
George Migausky*, MBA
Executive Vice President and Chief Financial Officer
William E.  Pullman*, M.D., Ph.D.
Executive Vice President and Chief Development Officer

*Denotes an Executive Officer

Stock quote

ExchangeNASDAQ (US Dollar)
Price$2.48
Change (%) Stock is Down 0.05 (1.98%)

Investor Relations Contacts

Ivana Magovcevic-Liebisch
Executive Vice President Corporate Development and General Counsel
Dyax Corp.
Phone: 617-225-2500


Nicole Jones
Director, Investor Relations and Corporate Communications
Dyax Corp.
Phone: 617-225-2500